Canopy Growth: Analyst Sees 4x Surge, But Doubts Remain

Canopy Growth (NASDAQ: CGC), a prominent player in the cannabis stock market, has seen its share price fall below $1, retracting gains from earlier this year. Despite this downturn, one analyst from Roth Capital Partners, Bill Kirk, remains notably bullish. He reiterated a buy rating on June 16, setting an ambitious price target of 5 Canadian dollars per share, which represents a potential quadrupling of its current trading value on the Toronto Stock Exchange.

Kirk's optimism is based on Canopy Growth's fiscal fourth quarter performance, where he believes the company would have achieved record adjusted EBITDA if not for one-time expenses. He also points to an improved market share, ongoing cost-reduction initiatives, and a reduced likelihood of future shareholder dilution as positive factors. However, the analyst's own fiscal year 2027 estimates suggest only a modest revenue growth of around 5.1% and continued negative adjusted EBITDA, albeit near breakeven.

This forecast raises questions about how such a substantial stock price increase can be realized. While meeting these projections might push the stock towards the median analyst target, achieving a fourfold surge seems unlikely based on the numbers alone. It is possible that the optimistic outlook hinges on faster-than-anticipated progress in U.S. federal marijuana legalization. Nevertheless, investors seeking exposure to the cannabis trend might find more stable investments in already profitable U.S.-based companies licensed at the state level.